Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 422

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1B
Chunk 422
---
 
  
    Convertible note conversion 
     64,127  
     -  
     100  
     -  
     -  
     100 
  
    Share issuance 
     176,673,037  
     18  
     48,401  
     -  
     -  
     48,419 
  
    Share issuance costs 
     -  
     -  
     (2,279) 
     -  
     -  
     (2,279)
  
    Net loss 
     -  
     -  
     -  
     (46,885) 
     -  
     (46,885)
  
    Currency translation adjustment, net of tax 
     -  
     -  
     -  
     -  
     208  
     208 
  
    Balance at June 30, 2025 
     194,379,996  
     20  
     174,049  
     (157,556) 
     (3,124) 
     13,389 

The accompanying notes are an integral part of
these consolidated financial statements.

F-5

INCANNEX HEALTHCARE INC.

Consolidated Statements of Cash Flows

(in thousands, except share and per share amounts)

(expressed
in U.S. Dollars, unless otherwise stated)

    For the fiscal year ended June 30, 

    2025  
    2024 
  
    Cash flows from operating activities: 

    Net loss 
     (46,885) 
     (18,459)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Depreciation and amortization 
     246  
     103 
  
    Stock-based compensation expense 
     2,609  
     8,928 
  
    Unrealized losses/(gains) on foreign currency remeasurement 
     294  
     28 
  
    Non-cash expense of ELOC commitment 
     1,048  
     - 
  
    Change in fair value of warrant liabilities 
     21,925  
     - 
  
    Change in fair value of convertible rights 
     (299) 
     -